Viveve Medical, Inc. (VIVE)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Breakdown | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -12.87 Million | -15.23 Million | -31.23 Million | -43.09 Million | -34.85 Million | -18.08 Million |
| Net Income | -22.02 Million | -21.91 Million | -42.52 Million | -49.98 Million | -36.95 Million | -20.11 Million |
| Depreciation & Amortization | 1.13 Million | 1.29 Million | 1.18 Million | 786 Thousand | 449 Thousand | 111 Thousand |
| Deferred income taxes | -747 Thousand | 2.31 Million | 1.13 Million | 179 Thousand | -221 Thousand | 162 Thousand |
| Stock-based compensation | 3.77 Million | 2.65 Million | 2.4 Million | 3.03 Million | 1.87 Million | 981 Thousand |
| Change in working capital | 4.11 Million | -497 Thousand | -2.33 Million | 398 Thousand | -1.3 Million | 275 Thousand |
| Other non-cash items | 862 Thousand | 918 Thousand | 8.9 Million | 2.49 Million | 1.3 Million | 657 Thousand |
| Investing Cash Flow | -456 Thousand | -781 Thousand | -1.08 Million | -2.14 Million | -3.4 Million | -256 Thousand |
| Investments in PPE | -456 Thousand | -781 Thousand | -1.08 Million | -2.14 Million | -905 Thousand | -256 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | -2.5 Million | - |
| Financing Cash Flow | 25.97 Million | 9.23 Million | 16.1 Million | 54.02 Million | 50.9 Million | 19.06 Million |
| Debt repayment | -3.98 Million | -1.34 Million | -322 Thousand | - | -10 Million | -4.83 Million |
| Dividends payments | - | - | -378 Thousand | - | - | - |
| Common Stock Repurchased | 704 Thousand | 341 Thousand | 56 Thousand | 233 Thousand | 76 Thousand | - |
| Common Stock Issuance | 25.82 Million | 341 Thousand | 16.27 Million | 53.79 Million | 31.64 Million | 13.88 Million |
| Other Financing Activities | 8.1 Million | 8.54 Million | 478 Thousand | 53.53 Million | 29.26 Million | 10.01 Million |
| Accounts receivables | 96 Thousand | 349 Thousand | 3.1 Million | 330 Thousand | -3.9 Million | -1.49 Million |
| Accounts payables | 599 Thousand | -727 Thousand | -2.38 Million | -805 Thousand | 1.71 Million | 1.65 Million |
| Inventory | 2.2 Million | 1.36 Million | -1.07 Million | -1.98 Million | -67 Thousand | -1.23 Million |
| Other working capital | 1.21 Million | -1.47 Million | -1.98 Million | 2.85 Million | 952 Thousand | 1.35 Million |
| Cash at beginning of period | 6.52 Million | 13.3 Million | 29.52 Million | 20.73 Million | 8.08 Million | 7.36 Million |
| Cash at end of period | 19.16 Million | 6.52 Million | 13.3 Million | 29.52 Million | 20.73 Million | 8.08 Million |
| Capital Expenditure | -456 Thousand | -781 Thousand | -1.08 Million | -2.14 Million | -905 Thousand | -256 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 12.63 Million | -6.78 Million | -16.21 Million | 8.79 Million | 12.64 Million | 726 Thousand |
| Free Cash Flow | -13.33 Million | -16.01 Million | -32.32 Million | -45.23 Million | -35.75 Million | -18.34 Million |
| Breakdown | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 FY | 2021 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -4.97 Million | -5.79 Million | -5.88 Million | -6.32 Million | -22.02 Million | -5.85 Million |
| Depreciation & Amortization | 174 Thousand | 188 Thousand | 204 Thousand | 240 Thousand | 1.13 Million | 246 Thousand |
| Deferred income taxes | - | - | - | -1.26 Million | -747 Thousand | 46 Thousand |
| Stock-based compensation | 868 Thousand | 909 Thousand | 960 Thousand | 1.01 Million | 3.77 Million | 1.08 Million |
| Change in working capital | 395 Thousand | -505 Thousand | -648 Thousand | 1.52 Million | 4.11 Million | 1.62 Million |
| Other non-cash items | 189 Thousand | 639 Thousand | 283 Thousand | 1.58 Million | 862 Thousand | 188 Thousand |
| Investing Cash Flow | -193 Thousand | -59 Thousand | -49 Thousand | -294 Thousand | -456 Thousand | -84 Thousand |
| Investments in PPE | -193 Thousand | -59 Thousand | -49 Thousand | -294 Thousand | -456 Thousand | -84 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 19 Thousand | 13 Thousand | 19 Thousand | 18 Thousand | 25.97 Million | 21 Thousand |
| Debt repayment | - | - | - | -29.76 Million | -3.98 Million | - |
| Dividends payments | - | - | - | -4.68 Million | -4.68 Million | - |
| Common Stock Repurchased | - | - | 19 Thousand | 704 Thousand | 704 Thousand | - |
| Common Stock Issuance | - | - | 1.26 Million | -25.78 Million | 25.82 Million | - |
| Other Financing Activities | 19 Thousand | 13 Thousand | -1.26 Million | 59.55 Million | 8.1 Million | - |
| Accounts receivables | -72 Thousand | -290 Thousand | 41 Thousand | -56 Thousand | 96 Thousand | 167 Thousand |
| Accounts payables | 204 Thousand | -698 Thousand | 122 Thousand | 188 Thousand | 599 Thousand | 630 Thousand |
| Inventory | 105 Thousand | 43 Thousand | -33 Thousand | 784 Thousand | 2.2 Million | 568 Thousand |
| Other working capital | 158 Thousand | 440 Thousand | -778 Thousand | 609 Thousand | 1.21 Million | 262 Thousand |
| Cash at beginning of period | 9.43 Million | 14.04 Million | 19.16 Million | 22.66 Million | 6.52 Million | 25.39 Million |
| Cash at end of period | 5.9 Million | 9.43 Million | 14.04 Million | 19.16 Million | 19.16 Million | 22.66 Million |
| Capital Expenditure | -193 Thousand | -59 Thousand | -49 Thousand | -294 Thousand | -456 Thousand | -84 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -3.52 Million | -4.61 Million | -5.11 Million | -3.5 Million | 12.63 Million | -2.72 Million |
| Free Cash Flow | -3.54 Million | -4.62 Million | -5.13 Million | -3.52 Million | -13.33 Million | -2.74 Million |
ERIC
MEB
CAL
TELO
TECHM
GOR